Clinical approach to genetic cardiomyopathy in children

Circulation

Volumn 94, Issue 8, 1996, Pages 2021-2038

  Schwartz, Marcy L ^a,b   Cox, Gerald F ^a,b   Lin, Angela E ^c   Korson, Mark S ^a,b   Perez Atayde, Antonio ^a,b   Lacro, Ronald V ^a,b   Lipshultz, Steven E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

cardiomyopathy; diagnosis; genetics

Indexed keywords

ADJUVANT THERAPY; BRAIN DISEASE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FAMILIAL DISEASE; GENETIC DISORDER; HUMAN; INBORN ERROR OF METABOLISM; MULTIPLE MALFORMATION SYNDROME; NEUROMUSCULAR DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0029838265     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.8.2021     Document Type: Review

References (215)

1. Bilgig A, Ozbarlas N, Ozkutlu S, Ozer S, Ozme S. Cardiomyopathies in children: clinical, epidemiological, and prognostic evaluation. Jpn Heart J. 1990;31:789-797.
2. Lewis A, Chabot M. Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol. 1991;68:365-369.
3. Taliercio CP, Seward JB, Driscoll DJ, Fisher LD, Gersh BJ, Tajik AJ. Idiopathic dilated cardiomyopathy in the young: clinical profile and natural history. J Am Coll Cardiol. 1985;6:1126-1131.
4. Kumar K, Thatai D, Saxena A, Srinivas V, Juneja R, Kothari SS, Shrivastava S, Lipshultz SE. Pediatric dilated cardiomyopathy (DCM): prognosis in a developing nation is comparable to developed nations. J Am Coll Cardiol. 1996;27:187A. Abstract.
5. Towbin JA. Molecular genetic aspects of cardiomyopathy. Biochem Med Metab Biol. 1993;49:285-320.
6. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med. 1994;330:913-919.
7. Kohlschutter A, Hausdorf G. Primary (genetic) cardiomyopathies in infancy: a survey of possible disorders and guidelines for diagnosis. Eur J Pediatr. 1986;145:454-459.
8. Servidei S, Bertini E, DiMauro S. Hereditary metabolic cardiomyopathies. Adv Pediatr. 1994;41:1-32.
9. Pierpont ME, Moller JH. Cardiac manifestations of genetic disease. In: Emmanouilides GC, Riemenschneider TA, Allen HD, Gutgesell HP, eds. Moss and Adams Heart Disease in Infants, Children, and Adolescents. 5th ed. Baltimore, Md: Williams & Wilkins; 1995; 2:1486-1520.
10. Brandenburg RO, Chazov E, Cherian G, Falase AO, Grosgogeat Y, Kawai C, Loogen F, Judez VM, Orinius E, Goodwin JF, Olsen EGJ, Oakley CM, Pisa Z. Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1981;64:437A-438A.
11. Boffa GM, Thiene G, Nava A, Volta SD. Cardiomyopathy: a necessary revision of the WHO classification. Int J Cardiol. 1991; 30:1-7.
12. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996; 93:841-842.
13. Brigden W. Uncommon myocardial diseases, the noncoronary cardiomyopathies. Lancet. 1957;2:1179-1184.
14. Goodwin JF, Gordon H, Hollman A, Bishop MB. Clinical aspects of cardiomyopathy. Br Med J. 1961;1:69-79.
15. Perloff JK. Cardiomyopathies in infants and children. In: Moss AJ, ed. Pediatrics Update: Reviews for Physicians. New York, NY: Elsevier Science Publishing Co; 1985:187-204.
16. Colan SD, Parness IA, Spevak PJ, Sanders SP. Developmental modulation of myocardial mechanics: age and growth related alterations in afterload and contractility. J Am Coll Cardiol. 1992;19:619-629.
17. Lipshultz SE, Orav EJ, Sanders SP, McIntosh K, Colan SD. Limitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virus. J Pediatr. 1994;125:563-570.
18. Rees A, Elbl F, Minhas K, Silinger R. Echocardiographic evidence of outflow tract obstruction in Pompe's disease (glycogen storage disease of the heart). Am J Cardiol. 1976;37:1103-1106.
19. Gussenhoven WJ, Busch HFM, Kleijer WJ, deVilleneuve VH. Echocardiographic features in the cardiac type of glycogen storage disease II. Eur Heart J. 1983;4:41-43.
20. Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT. Glycogen storage disease type III (glucogen debranching enzyme deficiency): correction of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med. 1992;116:896-900.
21. Miller CG, Alleyne GA, Brooks SEH. Gross cardiac involvement in glycogen storage disease type III. Br Heart J. 1972;34:862-864.
22. Servidei S, Riepe RE, Langston C, Tani LY, Bricker JT, Crisp-Lindgren N, Travers H, Armstrong D, DiMauro S. Severe cardiopathy in branching enzyme deficiency. J Pediatr. 1987;111:51-56.
23. Eishi Y, Takemura T, Sone R, Yamamura H, Narisawa K, Ichinohasama R, Tanaka M, Hatakeyama S. Glycogen storage disease confined to the heart with deficient activity of cardiac phosphorylase kinase: a new type of glycogen storage disease. Hum Pathol. 1985;16:193-197.
24. Servidei S, Metlay LA, Chodosh J, DiMauro S. Fatal infantile cardiopathy caused by phosphorylase b kinase deficiency. J Pediatr. 1988;113:82-85.
25. Tachi N, Tachi M, Sasaki K. Glycogen storage disease with normal acid maltase: skeletal and cardiac muscle. Pediatr Neurol. 1989; 5:60-63.
26. Hart ZH, Servidei S, Peterson PL, Chang CH, DiMauro S. Cardiomyopathy, mental retardation, and autophagic vacuolar myopathy. Neurology. 1987;37:1065-1068.
27. Schicken RM, Kerber RE, Ionasescu VV, Zellweger H. Cardiac manifestations of the mucopolysaccharidoses. Circulation. 1975;52: 700-705.
28. Renteria VG, Ferrans VJ, Roberts WC. The heart in the Hurler syndrome: gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol. 1976;38:487-501.
29. Gross DM, Williams JC, Caprioli C, Dominguez B, Howell RR. Echocardiographic abnormalities in the mucopolysaccharide storage diseases. Am J Cardiol. 1988;61:170-176.
30. Hayflick S, Rowe S, Kavanaugh-McHugh A, Olson JL, Valle D. Acute infantile cardiomyopathy as a presenting feature of mucopolysaccharidosis type VI. J Pediatr. 1992;120:269-272.
31. Miller G, Partridge A. Mucopolysaccharidosis type VI presenting in infancy with endocardial fibroelastosis and heart failure. Pediatr Cardiol. 1983;4:61-62.
32. Vervoort R, Islam MR, Sly WS, Zabot MT, Kleijer WJ, Chabas A, Fensom A, Young EP, Liebaers I, Lissens W. Molecular analysis of patients with β-glucuronidase deficiency presenting as hydrops fetalis or as early mucopolysaccharidosis VII. Am J Hum Genet. 1996;58:457-471.
33. Colucci WS, Lorell BH, Schoen FJ, Warhol MJ, Grossman W. Hypertrophic obstructive cardiomyopathy due to Fabry's disease. N Engl J Med. 1982;307:926-928.
34. Senocak F, Sarclar M, Ozkutlu S. Echocardiographic findings in some metabolic storage diseases. Jpn Heart J. 1994;35:635-643.
35. Millaire A, Warembourg A, Leys D, Tison E, Tondeux S, De Groote P, Ketelers JY, Fourrier F, Petit H, Ducloux G. La maladie de Refsum: a propos de deux cas reveles par une myocardiopathie. Ann Cardiol Angeio (Paris). 1990;39:173-178.
36. Rosenberg H, Frewen TC, Li MD, Gordon BL, Jung JH, Finlay JP, Roy PL, Grover D, Spence N. Cardiac involvement in diseases characterized by β-galactosidase deficiency. J Pediatr. 1985;106:78-80.
37. Kohlschutter A, Sieg K, Schulte FJ, Hayek HW, Goebel HH. Infantile cardiomyopathy and neuropathy with β-galactosidase deficiency. Eur J Pediatr. 1982;139:75-81.
38. Blieden LC, Desnick RJ, Carter JB, Krivit W, Moller JH, Sharp HL. Cardiac involvement in Sandhoff's disease. Am J Cardiol. 1974; 34:83-88.
39. Clayton PT, Winchester BG, Keir G. Hypertrophic obstructive cardiomyopathy in a neonate with carbohydrate-deficient glycoprotein syndrome. J Inherit Metab Dis. 1992;15:857-861.
40. Rodby RA, Tyszka TS, Williams JW. Reversal of cardiac dysfunction secondary to type 1 primary hyperoxaluria after combined liver-kidney transplantation. Am J Med. 1991;90:498-504.
41. Rutledge JC, Haas JE, Monnat R, Milstein JM. Hypertrophic cardiomyopathy is a component of subacute necrotizing encephalomyelopathy. J Pediatr. 1982;101:706-710.
42. Hoppel CL, Kerr DS, Dahms B, Roessman U. Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of the mitochondrial electron transport: fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy. J Clin Invest. 1987;80:71-77.
43. Reichmann H, Angelini C. Single muscle fibre analyses in 2 brothers with succinate dehydrogenase deficiency. Eur Neurol. 1993; 34:95-98.
44. Papadimitriou A, Neustein HB, DiMauro S, Stanton R, Bresolin N. Histiocytoid cardiomyopathy of infancy: deficiency of reducible cytochrome b in heart mitochondria. Pediatr Res. 1984;18:1023-1028.
45. Rimoldi M, Bottacchi E, Rossi L, Cornelio F, Uziel G, Di Donato S. Cytochrome c oxidase deficiency in muscles of a floppy infant without mitochondrial myopathy. J Neurol. 1982;227:201-207.
46. Zeviani M, Van Dyke DH, Servidei S, Bauserman SC, Bonilla E, Beaumont ET, Sharda J, VanderLaan K, DiMauro S. Myopathy and fatal cardiopathy due to cytochrome c oxidase deficiency. Arch Neurol. 1986;43:1198-1202.
47. Holme E, Greter J, Jacobson CE, Larsson NG, Lindstedt S, Nilsson KO, Oldfors A, Tulinius M. Mitochondrial ATP-synthase deficiency in a child with 3-methylglutaconic aciduria. Pediatr Res. 1992; 32:731-735.
48. Pastores GM, Santorelli FM, Shanske S, Gelb BD, Fyfe B, Wolfe D, Willner JP. Leigh syndrome and hypertrophic cardiomyopathy in an infant with a mitochondrial DNA point mutation (T8993G). Am J Med Genet. 1994;50:265-271.
49. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, Osame M, Tanaka H. Cardiac involvement in mitochondrial diseases: a study on 17 patients with documented mitochondrial DNA defects. Circulation. 1995;91:955-961.
50. Suzuki Y, Harada K, Miura Y, Sato W, Hayasaka K, Kawamura K, Takada G. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) decrease in diastolic left ventricular function assessed by echocardiography. Pediatr Cardiol. 1993;14:162-166.
51. Taniike M, Fukushima H, Yanagihara I, Tsukamoto H, Tanaka J, Fujimura H, Nagai T, Sano T, Yamaoka K, Inui K, Okada S. Mitochondrial tRNA Leu mutation in fatal cardiomyopathy. Biochem Biophys Res Commun. 1992;186:47-53.
52. Silvestri G, Santorelli FM, Shanske S, Whitley CB, Schimmenti LA, Smith SA, DiMauro S. A new mtDNA mutation in the tRNA(Leu [UUR]) gene associated with maternally inherited cardiomyopathy. Hum Mutation. 1994;3:37-43.
53. Merante F, Tein I, Benson L, Robinson BH. Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA (glycine) gene. Am J Hum Genet. 1994;55:437-446.
54. Channer KS, Channer JL, Campbell MJ, Rees JR. Cardiomyopathy in Kearns-Sayre syndrome. Br Heart J. 1988;59:486-490.
55. Servidei S, Zeviani M, Manfredi G, Ricci E, Silvestri G, Bertini E, Gellera C, DiMauro S, DiDonato S, Tonali P. Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology. 1991;41:1053-1059.
56. Kelley RI, Cheatham JP, Clarke BJ, Nigro MA, Powell BR, Sherwood GW, Sladky JT, Swisher WP. X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria. J Pediatr. 1991;119:738-747.
57. Figarella-Branger D, Pellissier JF, Scheinere, Wernert F, Desnuelle C. Defects of the mitochondrial respiratory chain complexes in three pediatric cases with hypotonia and cardiac involvement. J Neurol Sci. 1992;108:105-113.
58. Servidei S, Dionisi-Vici C, Bertini E. Sengers disease with deficiency of complexes I and IV. Ital J Neurol Sci. 1990;11:194. Abstract.
59. Cruysberg JRM, Sengers RCA, Pinckers A, Kubat K, van Haelst UJGM. Features of a syndrome with congenital cataract and hypertrophic cardiomyopathy. Am J Ophthalmol. 1986;102:740-749.
60. Romero NB, Marsac C, Paturneau-Jouas M, Ogier H, Magnier S, Fardeau M. Infantile familial cardiomyopathy due to mitochondrial complex I and IV associated deficiency. Neuromuscul Disord. 1993;3:31-42.
61. Toshihiro I, Sherwood G, Benson LN, Wilson GJ, Freedom RM, Rowe RD. Cardiac manifestations in disorders of fat and carnitine metabolism in infancy. J Am Coll Cardiol. 1988;11:1301-1308.
62. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RJ, Shug AL. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med. 1981;305:385-390.
63. Colin AA, Jaffe M, Shapira Y, Ne'eman Z, Gitman A, Korman S. Muscle carnitine deficiency presenting as familial fatal cardiomyopathy. Arch Dis Child. 1987;62:1170-1172.
64. Bautista J, Rafel E, Martinez A, Sainz I, Herrera J, Segura L, Chinchon I. Familial hypertrophic cardiomyopathy and muscle carnitine deficiency. Muscle Nerve. 1990;13:192-194.
65. Hug G, Bove KE, Soukup S. Lethal neonatal multiorgan deficiency of carnitine palmitoyl transferase II. N Engl J Med. 1991;325:1862-1864.
66. Stanley CA, Hale DE, Berry GT, Deleeuw S, Boxer J, Bonnefort JP. A deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane. N Engl J Med. 1992;327:19-23.
67. Yamaguchi S, Indo Y, Coates PM, Hashimoto T, Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1993;34:111-113.
68. Treem WR, Stanley CA, Hale DE, Leopold HB, Hyams JS. Hypoglycemia, hypotonia, and cardiomyopathy: the evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency. Pediatrics. 1991;87:328-333.
69. Rocchiccioli F, Wanders RJA, Aubourg P, Vianey-Liaud C, Ijlst L, Fabre M, Cartier N, Bougneres PF. Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: a cause of lethal myopathy and cardiomyopathy in early childhood. Pediatr Res. 1990;28:657-662.
70. Tein I, DeVivo DC, Hale DE, Clarke JT, Zinman H, Laxer R, Shore A, DiMauro S. Short chain-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy. Ann Neurol. 1991;30:415-419.
71. Niederwieser A, Steinmann B, Exner U, Neuheiser F, Redweik U, Wang M, Rampini S, Wendel U. Multiple acyl-CoA dehydrogenase deficiency (MADD) in a boy with non-ketotic hypoglycemia, hepatomegaly, muscle hypotonia, and cardiomyopathy: detection of N-isovalerylglutaric acid and its monoamide. Helv Pediatr Acta. 1983;38:9-26.
72. Massoud AF, Leonard JV. Cardiomyopathy in propionic acidemia. Eur J Pediatr. 1993;152:441-445.
73. Thompson GN, Danks DM, Edis DB. Cardiomyopathy as a complication of methylmalonic acidemia. In: Proceedings of the 28th SSIEM annual symposium; 1993:43; Birmingham, UK. Abstract.
74. Matalon R, Michaels K, Kaul R, Whitman V, Rodriguez-Novo J, Goodman S, Thornburn D. Malonic aciduria and cardiomyopathy. J Inherit Metab Dis. 1993;16:571-573.
75. Henry CG, Strauss AW, Keating JP, Hillman RE. Congestive cardiomyopathy associated with β-ketothiolase deficiency. J Pediatr. 1981;99:754-757.
76. Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM, Divry P, Hrebicek M, Lehnert W, Sartor K, Trefz FK, Rating D, Bremer HJ, Nyhan WL. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91:915-921.
77. Edwards MA, Green A, Colli A, Rylance G. Tyrosinaemia type I and hypertrophic obstructive cardiomyopathy. Lancet. 1987;1: 1437-1438.
78. Allanson J. Noonan syndrome. J Pediatr. 1987;24:9-13.
79. Sharland M, Morgan M, Smith G, Burch M, Patton MA. Genetic counselling in Noonan syndrome. Am J Med Genet. 1993;45: 437-440.
80. Neri G, Zollino M, Reynolds JF. The Noonan-CFC controversy. Am J Med Genet. 1991;39:367-370.
81. Blieden LC, Schneeweiss A, Shem-Tov A, Feigel A, Neufeld HN. Unifying link between Noonan's syndrome and LEOPARD syndrome? Pediatr Cardiol. 1983;4:168-169.
82. St. John Sutton MG, Tajik AJ, Giuliani ER, Gordon H, Su WP. Hypertrophic obstructive cardiomyopathy and lentiginosis: a little known neural ectodermal syndrome. Am J Cardiol. 1981;47: 215-217.
83. Lin AE, Garver KL. Cardiac abnormalities in neurofibromatosis. Neurofibromatosis. 1988;1:146-151.
84. Greenwood RD, Sommer A, Rosenthal A, Craenen J, Nadas AS. Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome. Am J Dis Child. 1977;131:293-294.
85. Ryan CA, Boyle MH, Burggraf GW. Reversible obstructive hypertrophic cardiomyopathy in the Beckwith-Wiedemann syndrome. Pediatr Cardiol 1989;10:225-228.
86. Chitayat D, Meuneir C, Hortop J, Beland M, Pinsky L, Zaor S, Der Kaloustian V, Robb L, Weksberg R. Lethal hypertrophic cardiomyopathy in one of two half-sibs with Beckwith-Wiedemann syndrome. Proc Greenwood Genet Ctr. 1993;12:91-92.
87. Brunner HG, Kapusta L. Familial cardiomyopathy, telecanthus and associated anomalies. Proc Greenwood Genet Ctr. 1990;9:94. Abstract.
88. Csanady M, Hogye M, Forster T. Hypertrophic cardiomyopathy associated with congenital deaf-mutism. Eur Heart J. 1987;8: 528-534.
89. Stevens CA, Bhakta MG. Cardiac abnormalities in the Rubenstein-Taybi syndrome. Proc Greenwood Genet Ctr. 1994;13:113. Abstract.
90. Narahara K, Kamada M, Takahashi Y, Tsuji K, Yokoyama Y, Ninomiya S, Seino Y. Case of ovarian dysgenesis and dilated cardiomyopathy supports existence of Malouf syndrome. Am J Med Genet. 1992;44:369-373.
91. Winship IM, Viljoen DL, Leary PM, DeMoor MM. Microcephalycardiomyopathy: a new autosomal recessive phenotype? J Med Genet. 1991;28:619-621.
92. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, Simitsis S, Scampardonis G. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J. 1986;56:321-326.
93. Rheuban KS, Blizzard RM, Parker MA, Carter T, Wilson T, Gutgesell HP. Hypertrophic cardiomyopathy in total lipodystrophy. J Pediatr. 1986;109:301-302.
94. Costello JM. Costello syndrome: update on the original cases and commentary. Am J Med Genet. 1996;62:199-201.
95. Johnson JP, Fries MH, Norton ME, Rosenblatt R, Feldman G, Yang S, Golabi M. Prenatal overgrowth with postnatal growth failure, dysmorphic facies, cutaneous features and cardiomyopathy: overlap of amicable, facio-cutaneous-skeletal (FCS), and Costello (CS) syndromes. Proc Greenwood Genet Ctr. 1993;12:98. Abstract.
96. Coffin GS. Developmental retardation with unusual facies, arthritis, and hearing impairment. Dysmorph Clin Genet. 1990;4:103-109.
97. Eastman JR, Bixler D. Facio-cardio-renal syndrome: a newly delineated recessive disorder. Clin Genet. 1977;11:424-430.
98. Najjar SS, Der Kaloustian VN, Ardati KO. Genital anomaly and cardiomyopathy: a new syndrome. Clin Genet. 1984;26:371-373.
99. Michaud JL, Heon E, Guilbert F, Weill J, Puech B, Benson L, Smallhorn JF, Shuman CT, Buncic JR, Levin AV, Weksberg R, Breviere GM. Natural history of Alstrom syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr. 1996;128: 225-229.
100. Ramer JC, Frankel CA, Ladda RL. Marden-Walker phenotype: spectrum of variability in three infants. Am J Med Genet. 1993; 45:285-291.
101. Sussman MD, Kelly T, Rosenbaum KN, Balian G. Abnormality of cartilage collagen in a patient with unclassified chondrodystrophy. J Orthop Res. 1984;2:339-345.
102. Russell-Eggitt IM, Taylor DSI, Clayton PT, Garner A, Kriss A, Taylor JF. Leber's congenital amaurosis: a new syndrome with cardiomyopathy. Br J Ophthalmol. 1989;73:250-254.
103. Char F, Readinger RI, McConnell JR, McCoy JR. A new (?) X-linked connective tissue disorder with joint hyperextensibility, mild cutis laxa, skeletal anomalies and idiopathic hypertrophic subaortic stenosis. Proc Greenwood Genet Ctr. 1987;6:174-177.
104. Bird LM, Krous HF, Eichenfeld LF, Swalwell CI, Jones MC. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy? Am J Med Genet. 1994;53:141-148.
105. Opitz JM, Hermann J, Gilbert EF, Matalon R. Simpson-Golabi-Behmel syndrome: follow-up of the Michigan family. Am J Med Genet. 1988;30:301-308.
106. Hockey A. X-linked intellectual handicap and precocious puberty with obesity in carrier females. Am J Med Genet. 1986;23:127-137.
107. Gilgenkrantz S, Vigneron C, Gregoire MJ, Pernot C, Raspiller A. Association of del(11)(p15.1p12), aniridia, catalase deficiency, and cardiomyopathy. Am J Med Genet. 1982;13:39-49.
108. Fryns JP, Chrzanowska K, Van den Berghe H. Hypohidrotic ectodermal dysplasia, primary hypothyroidism, and agenesis of the corpus callosum. J Med Genet. 1989;26:520-534.
109. Jennings MT, Hall JG, Kukolich M. Endocardial fibroelastosis, neurologic dysfunction and unusual facial appearance in two brothers, coincidentally associated with dominantly inherited macrocephaly. Am J Med Genet. 1980;5:271-276.
110. Krasnow N, Qazi QH, Yermakov V. A familial dilated cardiomyopathy associated with cataracts and hip-spine disease. Chest. 1985; 87:56-61.
111. Maries SL, Chudley AE. Ulnar agenesis and endocardial fibroelastosis. Am J Med Genet. 1990;37:258-260.
112. Hammill WH, Fyfe DA, Gillette PC, Taylor A, Dobson RL, Thompson RD. Cardiomyopathy with arrhythmia and ectodermal dysplasia: a previously unreported association. Am Heart J. 1988; 115:373-378.
113. Sacks HN, Crawley S, Ward JA, Fine RM. Familial cardiomyopathy, hypogonadism, and collagenoma. Ann Intern Med. 1980;93: 813-817.
114. Morris CA. Unknown case: mental retardation, craniosynostosis, multiple congenital anomalies, hypertrophic cardiomyopathy. Presented at the David W. Smith Workshop on Malformations and Morphogenesis; August 1993; Mount Tremblant, Quebec, Canada.
115. Shaw C, Bourke J, Dixon J. Proteus syndrome with cardiomyopathy and a myocardial mass. Am J Med Genet. 1993;46:145-148.
116. Cziner DG, Levin RI. The cardiomyopathy of Duchenne's muscular dystrophy and the function of dystrophin. Med Hypotheses. 1993; 40:169-173.
117. Backman E, Nylander E. The heart in Duchenne muscular dystrophy: a noninvasive longitudinal study. Eur Heart J. 1992;13: 1239-1244.
118. Palmucci L, Doriguzzi C, Mongini T, Chiado-Piat L, Restagno G, Carbonara A, Paolillo V. Dilating cardiomyopathy as the expression of Xp21 Becker type muscular dystrophy. J Neurol Sci. 1992; 111:218-221.
119. Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, Lotz BP. Deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N Engl J Med. 1996;334:362-366.
120. Forsberg H, Olofsson BO, Eriksson A, Andersson S. Cardiac involvement in congenital myotonic dystrophy. Br Heart J. 1990; 63:119-121.
121. Bione S, Maestrini E, Rivella S, Mancini M, Regis S, Romeo G, Toniolo D. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 1994;8:323-327.
122. Voit T, Krogmann O, Lenard HG, Neuen-Jacob E, Wechsler W, Goebel HH, Rahlf G, Lindinger A, Nienaber C, Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis. Neuropediatrics. 1988;19:62-71.
123. Hoshio A, Kotake H, Saito M, Ogino K, Fujimoto Y, Hasegawa J, Kosaka T, Mashiba H. Cardiac involvement in patients with limbgirdle muscular dystrophy. Heart Lung. 1987;16:439-441.
124. 123a.Cil E, Topaloglu H, Caglar M, Qzme S. Left ventricular structure and function by echocardiography in congenital muscular dystrophy. Brain Dev. 1994;16:301-303.
125. Verhiest W, Brucher JM, Goddeeris P, Lauweryns J, De Geest H. Familial centronuclear myopathy associated with 'cardiomyopathy.' Br Heart J. 1976;38:504-509.
126. Ishibashi-Ueda H, Imakita M, Yutani C, Takahashi S, Yamawa K, Kamiya T, Nonaka I. Congenital nemaline myopathy with dilated cardiomyopathy: an autopsy study. Hum Pathol. 1990;21:77-82.
127. Van Antwerpen CL, Gospe SM, Dentinger MP. Nemaline myopathy associated with hypertrophic cardiomyopathy. Pediatr Neurol. 1988;4:306-308.
128. Bertini E, Bosman C, Bevilacqua M, Ricci E, Gagliardi GM, Parisi F, Servidei S, Dionisi-Vici C, Ballerini L. Cardiomyopathy and multicore myopathy with accumulation of intermediate filaments. Eur J Pediatr. 1990;149:856-858.
129. Magliocco AM, Mitchell LB, Brownell AKW, Lester WM. Dilated cardiomyopathy in multicore myopathy. Am J Cardiol. 1988;63: 150-151.
130. Ackroyd RS, Finnegan JA, Green SH. Friedreich's ataxia: a clinical review with neurophysiological and echocardiographic findings. Arch Dis Child. 1984;59:217-221.
131. Morvan D, Komajda M, Doan LD, Brice A, Isnard R, Seck A, Lechat P, Agid Y, Grosgogeat Y. Cardiomyopathy in Friedreich's ataxia: a Doppler-echocardiographic study. Eur Heart J. 1992;13: 1393-1398.
132. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation. 1995;91:532-540.
133. Solomon SD, Geisterfer-Lowrance AAT, Vosberg HP, Hiller G, Jarcho JA, Morton CC, McBride WO, Mitchell AL, Bale AE, McKenna WJ, Seidman JG, Seidman CE. A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436, and CRI-L329 on chromosome 14 at q11-q12. Am J Hum Genet. 1990;47:389-394.
134. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-1114.
135. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med. 1995;332:1058-1064.
136. Watkins H, Conner D, Thierfelder L, Jarcho JA, MacRae C, McKenna WJ, Maron BJ, Seidman JG, Seidman CE. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat Genet. 1995;11:434-437.
137. MacRae C, Ghaisas N, McGarry K, McKenna W, Seidman JG, Seidman CE. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3. Circulation. 1994;90(pt 2):I-M. Abstract.
138. Remes AM, Hassinen IE, Ikaheimo MJ, Herva R, Hirvonen J, Peuhkurinen KJ. Mitochondrial DNA deletions in dilated cardiomyopathy: a clinical study employing endomyocardial sampling. J Am Coll Cardiol. 1994;23:935-942.
139. Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker PB III, Cody RJ, Fishman MC, Cox N, Kong A, Wooley CF, Seidman JG, Seidman CE. A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet. 1994;7:546-551.
140. Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J. 1992;123:1589-1593.
141. Cetta F, O'Leary PW, Seward JB, Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc. 1995;70:634-640.
142. Kaul U, Arora R, Rani S. Uhl's anomaly with rudimentary pulmonary valve leaflets: a clinical, hemodynamic, angiographic, and pathologic study. Am Heart J. 1980;100:673-677.
143. Gallo P, d'Amati G, Pelliccia F. Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum Pathol. 1992;23:948-952.
144. Rampazzo A, Nava A, Danieli GA, Buja G, Daliento L, Fasoli G, Scognamiglio R, Corrado D, Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 1994;3:959-962.
145. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of the left ventricular myocardium: a study of eight cases. Circulation. 1990;82:507-513.
146. Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Marrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA. Deletion of the dystrophin muscle promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993;329:921-925. Brief Report.
147. Berko BA, Swift M. X-linked dilated cardiomyopathy. N Engl J Med. 1987;316:1186-1191.
148. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M. X-linked dilated cardiomyopathy, molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation. 1993;87:1854-1865.
149. Mestroni L, Krajinovic M, Serverini GM, Falaschi A, Giacca M, Camerini F. Molecular genetics of dilated cardiomyopathy. Herz. 1994;19:97-104.
150. Branzi A, Romeo G, Specchia S, Lolli C, Binetti G, Devoto M, Bacchi M, Magnani B. Genetic heterogeneity of hypertrophic cardiomyopathy. Int J Cardiol. 1985;7:129-133.
151. Pearl W. Cardiovascular anomalies in Noonan's syndrome. Chest. 1977;71:677-679.
152. Hirsch HD, Gelband H, Garcia O, Gottlieb S, Tamer DM. Rapidly progressive obstructive cardiomyopathy in infants with Noonan's syndrome: report of two cases. Circulation. 1975;52:1161-1165.
153. Verlos A, LeMerrer M, Soyeur D. Cardio-facial-cutaneous syndrome: a syndrome distinct from Noonan syndrome. Ann Genet. 1988;31:230-234.
154. Jamieson CR, van der Burgt IV, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffery S, Patton MA, Mariman E. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet. 1994;8:357-360.
155. Sanyal SK, Johnson WW, Thapar MK, Pitner SE. An ultrastructural basis for electrocardiographic alterations associated with Duchenne's progressive muscular dystrophy. Circulation. 1978;57:1122-1129.
156. Manning GW, Cropp GJ. The electrocardiogram in progressive muscular dystrophy. Br Heart J. 1958;20:416-420.
157. Perloff JK, Roberts WC. The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. Am J Med. 1967;42:179-188.
158. Olofsson BO, Forsberg H, Andersson S, Bjerle P, Henriksson A, Wedin I. Electrocardiographic findings in myotonic dystrophy. Br Heart J. 1988;59:47-52.
159. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988;16:11141-11156.
160. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990;86:45-48.
161. Mirabella M, Servidei S, Manfredi G, Ricci E, Frustaci A, Bertini E, Rana M, Tonali P. Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology. 1993;43:2342-2345.
162. Miyashita H, Ikeda U, Shimada K, Natsume T, Arahata K. Backer muscular dystrophy with early manifestation of left heart failure. Intern Med. 1993;32:408-411.
163. Hoffman EP, Kunkel LM, Angelini C, Clarke A, Johnson M, Harris JB. Improved diagnosis of Becker muscular dystrophy by dystrophin testing. Neurology. 1989;39:1011-1017.
164. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L, Kupsky W, Chamberlain J, Caskey Y, Shapiro F, Kunkel LM. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988;318:1363-1368.
165. Borgeat A, Goy JJ, Sigwart U. Acute pulmonary edema as the inaugural symptom of Becker's muscular dystrophy in a 19-year-old patient. Clin Cardiol. 1987;10:127-129.
166. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol. 1979;43:1242-1244.
167. Ciro E, Nichols PF, Maron BJ. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two dimensional echocardiographic analysis. Circulation. 1983;67:1227-1233.
168. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol. 1981;48:418-428.
169. Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu F, Nishijo T, Umeda T, Machii K. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979;44:401-412.
170. Keren G, Belhassen B, Sherez J, Miller HI, Megidish R, Berenfeld D, Laniado S. Apical hypertrophic cardiomyopathy: evaluation by noninvasive techniques in 23 patients. Circulation. 1985;71:45-56.
171. Lever HM, Karam RF, Currie PJ, Healy BP. Hypertrophic cardiomyopathy in the elderly: distinctions from the young based on cardiac shape. Circulation. 1989;79:580-589.
172. Silver MM, Silver MD. Pathology of cardiomyopathies in childhood. Prog Pediatr Cardiol. 1992;1:8-39.
173. Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two dimensional echocardiography. Am J Cardiol. 1984;53:1087-1094.
174. Fananapazir L, Epstein ND. Genotype-phenotype correlations in hypertrophic cardiomyopathy: insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation. 1994;89:22-32.
175. Maron BJ, Bonow RO, Cannon RO III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy, I: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med. 1987;316:780-789.
176. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child. 1984;59:971-975.
177. Louie EK, Edwards LC. Hypertrophic cardiomyopathy. Prog Cardiovasc Dis. 1994;36:275-308.
178. Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelarr HD. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992;326:77-82.
179. Muntoni F, Melis MA, Ganau A, Dubowitz V. Transcription of the dystrophin gene in normal tissues and in skeletal muscle of a family with X-linked dilated cardiomyopathy. Am J Hum Genet. 1995;56:151-157.
180. Michels VV, Pastores GM, Moll PP, Driscoll DJ, Miller FA, Burnett JC, Rodeheffer RJ, Tajik JA, Beggs AH, Kunkel LM, Thibodeau SN. Dystrophin analysis in idiopathic dilated cardiomyopathy. J Med Genet. 1993;30:955-957.
181. Oldfors A, Eriksson BO, Kyllerman M, Martinsson T, Wahlstrom J. Dilated cardiomyopathy and the dystrophin gene: an illustrated review. Br Heart J. 1994;72:344-348.
182. Schmidt-Achert M, Fischer P, Pongratz D. Myocardial evidence of dystrophin mosaic in a Duchenne muscular dystrophy carrier. Lancet. 1992;340:1235-1236. Letter.
183. Lurie PR. Endomyocardial biopsies in cardiomyopathies of children. Prog Pediatr Cardiol. 1992;1:71-81.
184. Shaddy RE, Bullock EA. Efficacy of 100 consecutive right ventricular endomyocardial biopsies in pediatric patients using the right internal jugular venous approach. Pediatr Cardiol. 1993;14:5-8.
185. Leatherbury L, Chandra RS, Shapiro SR, Perry LW. Value of endomyocardial biopsy in infants, children, and adolescents with dilated or hypertrophic cardiomyopathy and myocarditis. J Am Coll Cardiol 1988;12:1547-1554.
186. Yoshizato T, Edwards WD, Alboliras ET, Hagler DJ, Driscoll DJ. Safety and utility of endomyocardial biopsy in infants, children, and adolescents: a review of 66 procedures in 53 patients. J Am Coll Cardiol. 1990;15:436-442.
187. Matitiau A, Perez-Atayde A, Sanders SP, Sluysman T, Parness IA, Spevak PJ, Colan SD. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation. 1994;90:1310-1318.
188. Becker AE, Caruso G. Myocardial disarray, a critical review. Br Heart J. 1982;47:527-538.
189. van der Bel-Kahn J. Muscle fiber disarray in common heart diseases. Am J Cardiol. 1977;40:355-364.
190. Bulkley BH, Weisfeldt ML, Hutchins GM. Isometric cardiac contraction, a possible cause of the disorganized myocardial pattern of idiopathic subaortic stenosis. N Engl J Med. 1977;296:135-139.
191. Corr PB, Creer MH, Yamada KA, Saffitz JE, Sobel BE. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. J Clin Invest. 1989;83:927-936.
192. Burlina AB, Milanesi O, Biban P, Bordugo A, Garavaglia B, Zacchello F, DiMauro S. Beneficial effect of sodium dichloroacetate in muscle cytochrome C oxidase deficiency. Eur J Pediatr. 1993;152:537-541.
193. Prezyrembel H. Therapy of mitochondrial disorders. J Inherit Metab Dis. 1987;10:129-146.
194. Rutledge SL, Havens PL, Haymond MW, McLean RH, Kan JS, Brusilow SW. Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr. 1990; 116:125-128.
195. Roth B, Younossi-Hartenstein A, Skopnik H, Leonard JV, Lehnert W. Haemodialysis for metabolic decompensation in propionic acidemia. J Inherit Metab Dis. 1987;10:147-151.
196. Riggs D, Weibley RE. Autopsies and the pediatric intensive care unit. Pediatr Clin North Am. 1994;41:1383-1393.
197. Korf BR. Advances in genetic diagnosis. Curr Opin Pediatr. 1993;5:720-727.
198. Dietz HC, Pyeritz RE. Molecular genetic approaches to the study of human cardiovascular disease. Annu Rev Physiol. 1994;56:763-796.
199. Duran M, Wanders RJA, de Jager JP, Dorland L, Bruinvis L, Ketting D, Ijlst L, van Sprang FS. 3-Hydroxydicarboxylic aciduria due to long-chain-3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. Eur J Pediatr. 1991;150:190-195.
200. Tripp ME, Katcher ML, Peters HA, Gilbert EF, Arya S, Hodach RJ, Shug AL. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. N Engl J Med. 1981;305:385-390.
201. Ostman-Smith I, Brown G, Johnson A, Land JM. Dilated cardiomyopathy due to type II X-linked 3-methylglutaconic aciduria: successful treatment with pantothenic acid. Br Heart J. 1994;72:349-353.
202. Hobbs JR, Hugh-Jones K, Barrett AJ, Byron N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone marrow transplantation. Lancet. 1981;2:709-712.
203. Krivit W, Pierpont ME, Ayaz K, Tsai M, Ramsay NK, Kersey JH, Weisdorf S, Sibley R, Snover R, McGovern MM. Bone marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): biochemical and clinical status 24 months after transplantation. N Engl J Med. 1984;311:1606-1611.
204. Vinallonga X, Sanz N, Balaguer A, Miro L, Ortega JJ, Casaldaliga J. Hypertrophic cardiomyopathy in mucopolysaccharidoses: regression after bone marrow transplantation. Pediatr Cardiol. 1992;13:107-109.
205. Gatzoulis MA, Vellodi A, Redington AN. Cardiac involvement in mucopolysaccharidoses: effect of allogenic bone marrow transplantation. Arch Dis Child. 1995;73:254-260.
206. Marin-Garcia J, Goldenthal MJ. Cardiomyopathy and abnormal mitochondrial function. Cardiovasc Res. 1994;28:456-463.
207. Stanley CA, Hale DE. Genetic disorders of mitochondrial fatty acid oxidation. Curr Opin Pediatr. 1994;6:476-481.
208. Rosenzweig A, Watkins H, Hwang DS, Miri M, McKenna W, Traill TA, Seidman JG, Seidman CE. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med. 1991;325:1753-1760.
209. Jarcho JA. Hypertrophic cardiomyopathy: how understanding molecular genetics helps explain clinical characteristics and guides management. Cardiol Rev. 1993;1:108-118.
210. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation. 1995;92:1336-1347.
211. Marian AJ, Mares A Jr, Kelly DP, Yu QT, Abchee AB, Hill R, Roberts R. Sudden cardiac death in hypertrophic cardiomyopathy: variability in phenotypic expression of β-myosin heavy chain mutations. Eur Heart J. 1995;16:368-376.
212. Nabel RG. Gene therapy for cardiovascular disease. Circulation. 1995;91:541-548.
213. Soonpaa MH, Koh GY, Klug MG, Field LJ. Formation of nascent intercalated disks between grafted fetal cardiomyocytes and host myocardium. Science. 1994;264:98-101.
214. Koh GY, Klug MG, Soonpas MH, Field LJ. Differentiation and long-term survival of C2C12 myoblast grafts in heart. J Clin Invest. 1993;92:1548-1554.
215. Blau HM, Springer ML. Gene therapy: a novel form of drug delivery. N Engl J Med. 1995;333:1204-1207.